Evidence map›Paper›PMID 37970450›Full record

Article3 Biotech2023

Synergistic antileishmanial activity of erythrodiol, uvaol, and oleanolic acid isolated from olive leaves of

Oumayma Lafi, Rym Essid, Laurence Lachaud, Carlos Jimenez, Jaime Rodríguez, Lucía Ageitos, Ridha Mhamdi, Leila Abaza

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Biofilm · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Oumayma LafiLaboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia.ORCID 0009-0009-7805-5996
Rym EssidLaboratory of Bioactive Substances, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia.ORCID 0000-0002-5956-1318
Laurence LachaudUMR, Univ Montpellier (IRD-CNRS), MIVEGEC, Montpellier, France.ORCID 0000-0001-6761-8161
Carlos JimenezCICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0003-2628-303X
Jaime RodríguezCICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-5348-6970
Lucía AgeitosCICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain.ORCID 0000-0002-2422-3773
Ridha MhamdiLaboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia.ORCID 0000-0002-2999-7604
Leila AbazaLaboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia.ORCID 0000-0001-9950-1478
Center of Biotechnogy of Borj Cédria · TNUniversidade da Coruña · ESCentre National de la Recherche Scientifique · FRTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the antileishmanial activity of biomolecules obtained from Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03825-3.

Indexed as

Antileishmanial activityOleaeuropaea L.Synergistic interactionTriterpenes

Identifiers

PMID37970450
PMCPMC10643720
OpenAlexW4388630903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.